Clinical trialNCT02477618CompletedPhase 3Interventional

A Study With SAGE-547 for Super-Refractory Status Epilepticus

SponsorSupernus Pharmaceuticals, Inc.Enrollment132Super-Refractory Status Epilepticus

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Eric Rosenthal, MD
Massachusetts General Hospital
Principal Investigator
clinicaltrials.gov ↗
Mark Wainwright, MD, PhD
Ann & Robert H Lurie Children's Hospital of Chicago
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

171 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria

Sage Investigational Site
Innsbruck, Austria
Sage Investigational Site
Salzburg, Austria

Canada

Sage Investigational Site
Vancouver, British Columbia, Canada
Sage Investigational Site
Hamilton, Ontario, Canada
Sage Investigational Site
Kingston, Ontario, Canada
Sage Investigational Site
London, Ontario, Canada
Sage Investigational Site
Montreal, Quebec, Canada
Sage Investigational Site
Montreal, Quebec, Canada
Sage Investigational Site
Montreal, Quebec, Canada
Sage Investigational Site
Montreal, Quebec, Canada
Sage Investigational Site
Montreal, Quebec, Canada

Denmark

Sage Investigational Site
Copenhagen, Denmark

Estonia

Sage Investigational Site
Tallinn, Estonia
Sage Investigational Site
Tallinn, Estonia
Sage Investigational Site
Tartu, Estonia

Finland

Sage Investigational Site
Helsinki, Finland
Sage Investigational Site
Kuopio, Finland

France

Sage Investigational Site
Bron, France
Sage Investigational Site
Dijon, France
Sage Investigational Site
Lille, France
Sage Investigational Site
Limoges, France
Sage Investigational Site
Lyon, France
Sage Investigational Site
Paris, France

Germany

Sage Investigational Site
Hamburg, Germany
Sage Investigational Site
Marburg, Germany
Sage Investigational Site
Osnabrück, Germany

Hungary

Sage Investigational Site
Balassagyarmat, Hungary
Sage Investigational Site
Budapest, Hungary
Sage Investigational Site
Budapest, Hungary

Israel

Sage Investigational Site
Ashkelon, Israel
Sage Investigational Site
Holon, Israel
Sage Investigational Site
Holon, Israel
Sage Investigational Site
Jerusalem, Israel
Sage Investigational Site
Petah Tikva, Israel
Sage Investigational Site
Tel Litwinsky, Israel
Sage Investigational Site
Tzrifin, Israel

Italy

Sage Investigational Site
Bologna, Italy
Sage Investigational Site
Florence, Italy
Sage Investigational Site
Milan, Italy
Sage Investigational Site
Milan, Italy

131 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2015
Primary completion: 18 Jul 2017
Completion: 11 Aug 2017
Last update posted: 14 Oct 2025
Registered enrollment: 132
Registry id: NCT02477618

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.